Consun Pharmaceutical Group Limited (01681)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
An Meng17-Jan-24Ch, CEO
20-Jun-25MbNCCeased to be a member of the Nomination Committee in response to the amended Corporate Governance Code and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
09-Jul-2117-Jan-24Ch
24-Mar-2109-Jul-21ED, VP
An Yubao24-Jan-1109-Jul-21Ch
Chen Yujun24-Feb-25CFO
31-May-1924-Feb-25INEDResigned due to the reallocation of responsibilities in the Group’s management. Appointed as the Chief Financial Officer
24-Feb-25MbNCResigned due to the reallocation of responsibilities in the Group’s management. Appointed as the Chief Financial Officer
Cheng Xinxin02-Dec-1331-May-19INED
Feng Zhongshi02-Dec-13INED
08-Apr-25MbACCeased to be a member of the Audit Committee.
25-Mar-24Chairman and Member of the Nomination CommitteeNo reasons provided
Gao Haien22-Aug-24CoSec
15-Apr-1431-May-17CoSec
Li Qian01-Jun-1817-Jan-24CEO, V-ChDue to health reasons
17-Jan-24EDDue to health reasons
24-Dec-1201-Jun-18CEO
Li Yikai21-Jun-24INED
Li Zhuoguang24-Feb-25INED
08-Apr-25MbNCCeased to be a member of the Nomination Committee and the ESG Committee.
Lin Sheng01-Apr-1613-Apr-18NED
Mr. Fang Peicheng24-Feb-25CFOCeased to concurrently serve as Chief Financial Officer but continued to hold the position of vice president of the Group.
Su Yuanfu02-Dec-1325-Mar-24INEDHe would like to devote more time to his other personal commitments
Tang Ning01-Jun-1829-May-20ED
Wang Shun Long24-Dec-1231-May-17NED
Wang Zi Han24-Dec-1228-Mar-14NED
Xu Hanxing24-Mar-2131-May-24ED
Yau Chi Ming22-Aug-24CoSecNo reasons provided
Yau Esmond Chi Ming16-Mar-1322-Aug-24CFO, CoSec
Young Peter Wai Po24-Dec-1228-May-14Co-Fdr, NED
Zhang Lihua20-Jun-25MbNC
09-Jul-21NED
25-Mar-24MbACNo reasons provided
Zhu Quan24-Dec-1225-Sep-25EDProfessor Zhu would like to devote more time on his other affair. Redesignated as a non-executive Director